A Model of Lung Tumor Angiogenesis in a Biomimetic Poly(ethylene glycol)-based Hydrogel System

Tumor angiogenesis is critical to tumor growth and metastasis, yet much is unknown about the role vascular cells play in the tumor microenvironment. A major outstanding challenge associated with studying tumor angiogenesis is that existing preclinical models are limited in their recapitulation of in vivo cellular organization in 3D. This disparity highlights the need for better approaches to study the dynamic interplay of relevant cells and signaling molecules as they are organized in the tumor microenvironment. In this thesis, we combined 3D culture of lung adenocarcinoma cells with adjacent 3D microvascular cell culture in 2-layer cell-adhesive, proteolytically-degradable poly(ethylene glycol) (PEG)-based hydrogels to study tumor angiogenesis and the impacts of neovascularization on tumor cell behavior.

In initial studies, 344SQ cells, a highly metastatic, murine lung adenocarcinoma cell line, were characterized alone in 3D in PEG hydrogels. 344SQ cells formed spheroids in 3D culture and secreted proangiogenic growth factors into the conditioned media that significantly increased with exposure to transforming growth factor beta 1 (TGF-β1), a potent tumor progression-promoting factor. Vascular cells alone in hydrogels formed tubule networks with localized activated TGF-β1. To study cancer cell-vascular cell interactions, the engineered 2-layer tumor angiogenesis model with 344SQ and vascular cell layers was employed. Large, invasive 344SQ clusters developed at the interface between the layers, and were not evident further from the interface or in control hydrogels without vascular cells. A modified model with spatially restricted 344SQ and vascular cell layers confirmed that observed 344SQ cluster morphological changes required close proximity to vascular cells. Additionally, TGF-β1 inhibition blocked endothelial cell-driven 344SQ migration.

Two other lung adenocarcinoma cell lines were also explored in the tumor angiogenesis model: primary tumor-derived metastasis-incompetent, murine 393P cells and primary tumor-derived metastasis-capable human A549 cells. These lung cancer cells also formed spheroids in 3D culture and secreted proangiogenic growth factors into the conditioned media. Epithelial morphogenesis varied for the primary tumor-derived cell lines compared to 344SQ cells, with far less epithelial organization present in A549 spheroids. Additionally, 344SQ cells secreted the highest concentration of two of the three angiogenic growth factors assessed. This finding correlated to 344SQ exhibiting the most pronounced morphological response in the tumor angiogenesis model compared to the 393P and A549 cell lines.

Overall, this dissertation demonstrates the development of a novel 3D tumor angiogenesis model that was used to study vascular cell-cancer cell interactions in lung adenocarcinoma cell lines with varying metastatic capacities. Findings in this thesis have helped to elucidate the role of vascular cells in tumor progression and have identified differences in cancer cell behavior in vitro that correlate to metastatic capacity, thus highlighting the usefulness of this model platform for future discovery of novel tumor angiogenesis and tumor progression-promoting targets.

Biocompatibility Assessment of Biosorbable Polymer Coated Nitinol Alloys

Owing to an increased risk of aging population and a higher incidence of coronary artery disease (CAD), there is a need for more reliable and safer treatments. Numerous varieties of durable polymer-coated drug eluting stents (DES) are available in the market in order to mitigate in-stent restenosis. However, there are certain issues regarding their usage such as delayed arterial healing, thrombosis, inflammation, toxic corrosion by-products, mechanical stability and degradation. As a result, significant amount of research has to be devoted to the improvement of biodegradable polymer-coated implant materials in an effort to enhance their bioactive response. In this investigation, magneto-electropolished (MEP) and a novel biodegradable polymer coated ternary Nitinol alloys, NiTiTa and NiTiCr were prepared to study their bio and hemocompatibility properties. The initial interaction of a biomaterial with its surroundings is dependent on its surface characteristics such as, composition, corrosion resistance, work of adhesion and morphology. In-vitro corrosion tests such as potentiodynamic polarization and electrochemical impedance spectroscopic (EIS) studies were conducted to determine the coating stability and longevity. In-vitro hemocompatibility studies and HUVEC cell growth was performed to determine their thrombogenic and biocompatibility properties. Critical delamination load of the polymer coated Nitinol alloys was determined using Nano-scratch analysis. Sulforhodamine B (SRB) assays were performed to elucidate the effect of metal ions leached from Nitinol alloys on the viability of HUVEC cells. Scanning Electron Microscopy (SEM), X-ray Photoelectron Spectroscopy (XPS), contact angle meter and X-ray diffraction (XRD) were used to characterize the surface of the alloys. MEP treated and polymer coated (PC) Nitinol alloys displayed a corrosion resistant polymer coating as compared to uncoated alloys. MEP and PC has resulted in reduced Ni and Cr ion leaching from NiTi5Cr and subsequently low cytotoxicity. Thrombogenicity tests revealed significantly less platelet adhesion and confluent endothelial cell growth on polymer coated and uncoated ternary MEP Nitinol alloys. Finally, this research addresses the bio and hemocompatibility of MEP + PC ternary Nitinol alloys that could be used to manufacture blood contacting devices such as stents and vascular implants which can lead to lower U.S. healthcare spending.

Tissue-specific bioscaffolds for adipose-derived stem/stromal cell expansion and delivery

Decellularized adipose tissue (DAT) is a promising biomaterial for soft tissue regeneration, and it provides a highly conducive microenvironment for human adipose-derived stem/stromal cell (ASC) attachment, proliferation, and adipogenesis. This thesis focused on developing techniques to fabricate 3-D bioscaffolds from enzymatically-digested DAT as platforms for ASC culture and delivery in adipose tissue engineering and large-scale ASC expansion. Initial work investigated chemically crosslinked microcarriers fabricated from pepsin-digested DAT as injectable adipo-inductive substrates for ASCs. DAT microcarriers highly supported ASC adipogenesis compared to gelatin microcarriers in a CELLSPIN system, as confirmed by glycerol-3-phosphate dehydrogenase (GPDH) enzyme activity, lipid accumulation, and endpoint RT-PCR. ASCs cultured on DAT microcarriers in proliferation medium also had elevated PPARγ, C/EBPα, and LPL expression which suggested adipo-inductive properties. In vivo testing of the DAT microcarriers exhibited stable volume retention and enhanced cellular infiltration, tissue remodeling, and angiogenesis. Building from this work, non-chemically crosslinked porous foams and bead foams were fabricated from α-amylase-digested DAT for soft tissue regeneration. Foams were stable and strongly supported ASC adipogenesis based on GPDH activity and endpoint RT-PCR. PPARγ, C/EBPα, and LPL expression in ASCs cultured on the foams in proliferation media indicated adipo-inductive properties. Foams with Young’s moduli similar to human fat also influenced ASC adipogenesis by enhanced GPDH activity. In vivo adipogenesis accompanied by a potent angiogenic response and rapid resorption showed their potential use in wound healing applications. Finally, non-chemically crosslinked porous microcarriers synthesized from α-amylase-digested DAT were investigated for ASC expansion. DAT microcarriers remained stable in culture and supported significantly higher ASC proliferation compared to Cultispher-S microcarriers in a CELLSPIN system. ASC immunophenotype was preserved for all expanded groups, with reduced adhesion marker expression under dynamic conditions. DAT microcarrier expansion upregulated ASC expression of early adipogenic (PPARγ, LPL) and chondrogenic (COMP) markers without inducing a mature phenotype. DAT microcarrier expanded ASCs also showed similar levels of adipogenesis and osteogenesis compared to Cultispher-S despite a significantly higher population fold-change, and had the highest level of chondrogenesis among all groups. This study demonstrates the promising use of DAT microcarriers as a clinically relevant strategy for ASC expansion while maintaining multilineage differentiation capacity.

Water-retaining hydrogels – the unsung heroes of medicine

Hydrogels, materials that can absorb and retain large quantities of water, could revolutionise medicine. Our bodies contain up to 60% water, but hydrogels can hold up to 90%. It is this similarity to human tissue that has led researchers to examine if these materials could be used to improve the treatment of a range of medical conditions including heart disease and cancer.

Fibronectin/phosphorylcholine coatings on fluorocarboned surfaces: a study upon adsorption and grafting processes

Depuis ces dernières décennies, le domaine des biomatériaux a connu un essor considérable, évoluant de simples prothèses aux dispositifs les plus complexes pouvant détenir une bioactivité spécifique. Outre, le progrès en science des matériaux et une meilleure compréhension des systèmes biologiques a offert la possibilité de créer des matériaux synthétiques pouvant moduler et stimuler une réponse biologique déterminée, tout en améliorant considérablement la performance clinique des biomatériaux. En ce qui concerne les dispositifs cardiovasculaires, divers recouvrements ont été développés et étudiés dans le but de modifier les propriétés de surface et d’améliorer l’efficacité clinique des tuteurs. En effet, lorsqu’un dispositif médical est implanté dans le corps humain, son succès clinique est fortement influencé par les premières interactions que sa surface établit avec les tissus et les fluides biologiques environnants. Le recouvrement à la surface de biomatériaux par diverses molécules ayant des propriétés complémentaires constitue une approche intéressante pour atteindre différentes cibles biologiques et orienter la réponse de l’hôte. De ce fait, l’élucidation de l’interaction entre les différentes molécules composant les recouvrements est pertinente pour prédire la conservation de leurs propriétés biologiques spécifiques. Dans ce travail, des recouvrements pour des applications cardiovasculaires ont été créés, composés de deux molécules ayant des propriétés biologiques complémentaires : la fibronectine (FN) afin de promouvoir l’endothélialisation et la phosphorylcholine (PRC) pour favoriser l’hémocompatibilité. Des techniques d’adsorption et de greffage ont été appliquées pour créer différents recouvrements de ces deux biomolécules sur un polymère fluorocarboné déposé par traitement plasma sur un substrat en acier inoxydable. Dans un premier temps, des films de polytétrafluoroéthylène (PTFE) ont été utilisés en tant que surface modèle afin d’explorer l’interaction de la PRC et de la FN avec les surfaces fluorocarbonées ainsi qu’avec des cellules endothéliales et du sang. La stabilité des recouvrements de FN sur l’acier inoxydable a été étudiée par déformation, mais également par des essais statiques et dynamiques sous-flux. Les recouvrements ont été caractérisés par Spectroscopie Photoéléctronique par Rayons X, immunomarquage, angle de contact, Microscopie Électronique de Balayage, Microscopie de Force Atomique et Spectrométrie de Masse à Ionisation Secondaire à Temps de Vol (imagerie et profilage en profondeur). Des tests d’hémocompatibilité ont été effectués et l’interaction des cellules endothéliales avec les recouvrements a également été évaluée. La FN greffée a présenté des recouvrements plus denses et homogènes alors que la PRC quant à elle, a montré une meilleure homogénéité lorsqu’elle était adsorbée. La caractérisation de la surface des échantillons contenant FN/PRC a été corrélée aux propriétés biologiques et les recouvrements pour lesquels la FN a été greffée suivie de l’adsorption de la PRC ont présenté les meilleurs résultats pour des applications cardiovasculaires : la promotion de l’endothélialisation et des propriétés d’hémocompatibilité. Concernant les tests de stabilité, les recouvrements de FN greffée ont présenté une plus grande stabilité et densité que dans le cas de l’adsorption. En effet, la pertinence de présenter des investigations des essais sous-flux versus des essais statiques ainsi que la comparaison des différentes stratégies pour créer des recouvrements a été mis en évidence. D’autres expériences sont nécessaires pour étudier la stabilité des recouvrements de PRC et de mieux prédire son interaction avec des tissus in vivo.

Recouvrements à base de dextrane pour applications médicales

L’ingénierie des biomatériaux a connu un essor prodigieux ces dernières décennies passant de matériaux simples à des structures plus complexes, particulièrement dans le domaine cardiovasculaire. Cette évolution découle de la nécessité des biomatériaux de permettre la synergie de différentes propriétés, dépendantes de leurs fonctions, qui ne sont pas forcément toutes compatibles. Historiquement, les premiers matériaux utilisés dans la conception de dispositifs médicaux étaient ceux présentant le meilleur compromis entre les propriétés physico-chimiques, mécaniques et biologiques que nécessitait leur application. Cependant, il se peut qu’un tel dispositif possède les bonnes propriétés physico-chimiques ou mécaniques, mais que sa biocompatibilité soit insuffisante induisant ainsi des complications cliniques. Afin d’améliorer ces propriétés biologiques tout en conservant les propriétés de volume du matériau, une solution est d’en modifier la surface. L’utilisation d’un revêtement permet alors de moduler la réponse biologique à l’interface biomatériau-hôte et de diminuer les effets indésirables. Ces revêtements sont optimisés selon deux critères principaux : la réponse biologique et la réponse mécanique. Pour la réponse biologique, les deux approches principales sont de mettre au point des revêtements proactifs qui engendrent l’adhérence, la prolifération ou la migration cellulaire, ou passifs, qui, principalement, sont inertes et empêchent l’adhérence de composés biologiques. Dans certains cas, il est intéressant de pouvoir favoriser certaines cellules et d’en limiter d’autres, par exemple pour lutter contre la resténose, principalement due à la prolifération incontrôlée de cellules musculaires lisses qui conduit à une nouvelle obstruction de l’artère, suite à la pose d’un stent. La recherche sur les revêtements de stents vise, alors, à limiter la prolifération de ces cellules tout en facilitant la ré-endothélialisation, c’est-à-dire en permettant l’adhérence et la prolifération de cellules endothéliales. Dans d’autres cas, il est intéressant d’obtenir des surfaces limitant toute adhérence cellulaire, comme pour l’utilisation de cathéter. Selon leur fonction, les cathéters doivent empêcher l’adhérence cellulaire, en particulier celle des bactéries provoquant des infections, et être hémocompatibles, principalement dans le domaine vasculaire. Il a été démontré lors d’études précédentes qu’un copolymère à base de dextrane et de poly(méthacrylate de butyle) (PBMA) répondait aux problématiques liées à la resténose et qu’il possédait, de plus, une bonne élasticité, propriété mécanique importante due à la déformation que subit le stent lors de son déploiement. L’approche de ce projet était d’utiliser ce copolymère comme revêtement de stents et d’en améliorer l’adhérence à la surface en formant des liens covalents avec la surface. Pour ce faire, cela nécessitait l’activation de la partie dextrane du copolymère afin de pouvoir le greffer à la surface aminée. Il était important de vérifier pour chaque étape l’influence des modifications effectuées sur les propriétés biologiques et mécaniques des matériaux obtenus, mais aussi d’un point de vue de la chimie, l’influence que cette modification pouvait induire sur la réaction de copolymérisation. Dans un premier temps, seul le dextrane est considéré et est modifié par oxydation et carboxyméthylation puis greffé à des surfaces fluorocarbonées aminées. L’analyse physico-chimique des polymères de dextrane modifiés et de leur greffage permet de choisir une voie de modification préférentielle qui n’empêchera pas ultérieurement la copolymérisation. La carboxyméthylation permet ainsi d’obtenir un meilleur recouvrement de la surface tout en conservant la structure polysaccharidique du dextrane. Le greffage du dextrane carboxyméthylé (CMD) est ensuite optimisé selon différents degrés de modification, tenant compte aussi de l’influence que ces modifications peuvent induire sur les propriétés biologiques. Finalement, les CMD précédemment étudiés, avec des propriétés biologiques définies, sont copolymérisés avec des monomères de méthacrylate de butyle (BMA). Les copolymères ainsi obtenus ont été ensuite caractérisés par des analyses physico-chimiques, biologiques et mécaniques. Des essais préliminaires ont montrés que les films de copolymères étaient anti-adhérents vis-à-vis des cellules, ce qui a permis de trouver de nouvelles applications au projet. Les propriétés élastiques et anti-adhérentes présentées par les films de copolymères CMD-co-PBMA, les rendent particulièrement intéressants pour des applications comme revêtements de cathéters.

Étude de la guérison des plaies cornéennes grâce à la cornée reconstruite par génie tissulaire

La cornée est la couche la plus antérieure de l’oeil et sa transparence permet de laisser passer les ondes lumineuses vers la rétine. Cependant, la localisation de la cornée la prédispose à des blessures chimiques et mécaniques. La guérison des blessures cornéennes est un mécanisme complexe faisant intervenir la mort cellulaire, la migration, la prolifération, la différenciation et le remodelage de la matrice extracellulaire (MEC). Dans cette étude, nous avons utilisé la cornée humaine reconstruite par génie tissulaire composée d’un épithélium et d’un stroma afin d’étudier les mécanismes cellulaires et moléculaires de la guérison des plaies, en particulier le remodelage de la MEC exercé par les métalloprotéinases matricielles (MMPs). Les analyses en profilage génique sur biopuces à ADN nous ont permis de démontrer que l’expression de plusieurs gènes était dérégulée lors de la guérison des plaies dans notre modèle. L’expression des gènes codant pour les MMPs, tel que confirmée en qPCR, est augmentée dans l’épithélium migrant afin de recouvrir la plaie. Les analyses en zymographie sur gel ont démontré que les MMPs étaient converties en leur forme enzymatiquement active au fur et à mesure que la lésion se referme. Par ailleurs, nous avons démontré que l’expression des MMPs par les cellules épithéliales est influencée par la présence des fibroblastes dans le stroma ainsi que par leur sécrétion d’une MEC enrichie en collagènes. De plus, les analyses en spectrométrie de masse ont confirmé que la présence d’un épithélium stratifié est requise pour la synthèse et l’organisation adéquate de la MEC. Enfin, les résultats de ces travaux améliorent nos connaissances des mécanismes cellulaires et moléculaires qui modulent la guérison des plaies cornéennes et pourront certainement mener à des progrès en clinique, notamment au niveau du développement de thérapies visant à traiter les troubles de la cornée.

Avanço dos biomateriais e técnicas na correção dos defeitos ósseos maxilares

Introdução: Determinar as causas da perda óssea nos maxilares, compreender os mecanismos biológicos desencadeados após a perda dental e criar recursos técnicos no intúito de prevenir e/ou minimizar as sequélas decorrentes, tem sido ao longo dos anos uma das vertentes de maior pesquisa e desenvolvimento na medicina dental . Objetivo: Assim, o objetivo desta dissertação é realizar uma revisão da literatura sobre os avanços nos biomateriais e técnicas na correção dos defeitos ósseos maxilares, para que seja possível, futuramente, ampliar as suas aplicações em Medicina Dentária, ultrapassando as limitações das técnicas e materiais existentes atualmente. Metodologia: Para isso, foi realizada uma pesquisa de artigos na base de dados PubMed, Bireme, Lilacs, Medline, revistas e periódicos nos idiomas: português, inglês e espanhol; assim como livros consagrados na literatura médico-odontológica,com o recurso a limites e palavras-chave de forma a refinar essa pesquisa. Desenvolvimento: Os avanços nos biomateriais e técnicas na correção dos defeitos ósseos maxilares tem seguido, assim como os implantes dentais, dois principais eixos de pesquisa, primeiro no que diz respeito aos biomateriais empregados pós-exodontia, a prevenir a reabsorção osséa e aqueles utilizados à fim de corrigir defeitos já existentes; a aplicação destes materiais recai sobre fatores que são decisivos na escolha do cirurgião, tais como: disponibilidade, necessidade de procedimento cirúrgico adicional, compatibilidade, morbidade do enxerto, qualidade do osso resultante e tempo de neo-formação. Segundo, as técnicas e recursos desenvolvidos para garantir a eficáz correção do defeito, assim como proporcionar procedimentos menos traumaticos ao organismo e de maior simplicidade e previsibilidade na sua execução e reprodução pelos profissionais. Discussão: Os trabalhos desenvolvidos em volta dos biomateriais atualmente buscam não só o substituto ideal, mas sim a melhoria na interação entre o osso hospedeiro e o biomaterial enxertado perante os recursos já utilizados e consagrados pelas literaturas; assim como a utilização das técnicas já protocoladas de forma associada a estes novos materiais. Conclusão: As pesquisas sobre o aperfeiçoamento do processo de regeneração óssea nos defeitos maxilares avançam na questão de promover a rápida e eficaz interação entre organismo e biomaterial, a fim de trazer soluções para problemas como a anti-genicidade, previsibilidade dimensional, menor tempo entre a enxertia e a reabilitação protética e agrega-se a utilização de recursos técnicos práticos, uma vez que o planejamento da reabilitação inicia-se nas decisões pré-exodontias e pré-implantares.

Artificial Skin - Culturing of Different Skin Cell Lines for Generating an Artificial Skin Substitute on Cross-Weaved Spider Silk Fibres

Background: In the field of Plastic Reconstructive Surgery the development of new innovative matrices for skin repair is in urgent need. The ideal biomaterial should promote attachment, proliferation and growth of cells. Additionally, it should degrade in an appropriate time period without releasing harmful substances, but not exert a pathological immune response. Spider dragline silk from Nephila spp meets these demands to a large extent. Methodology/Principal Findings: Native spider dragline silk, harvested directly out of Nephila spp spiders, was woven on steel frames. Constructs were sterilized and seeded with fibroblasts. After two weeks of cultivating single fibroblasts, keratinocytes were added to generate a bilayered skin model, consisting of dermis and epidermis equivalents. For the next three weeks, constructs in co-culture were lifted on an originally designed setup for air/liquid interface cultivation. After the culturing period, constructs were embedded in paraffin with an especially developed program for spidersilk to avoid supercontraction. Paraffin cross-sections were stained in Haematoxylin & Eosin (H&E) for microscopic analyses. Conclusion/Significance: Native spider dragline silk woven on steel frames provides a suitable matrix for 3 dimensional skin cell culturing. Both fibroblasts and keratinocytes cell lines adhere to the spider silk fibres and proliferate. Guided by the spider silk fibres, they sprout into the meshes and reach confluence in at most one week. A well-balanced, bilayered cocultivation in two continuously separated strata can be achieved by serum reduction, changing the medium conditions and the cultivation period at the air/liquid interphase. Therefore spider silk appears to be a promising biomaterial for the enhancement of skin regeneration.

Interactions between Spider Silk and Cells - NIH/3T3 Fibroblasts Seeded on Miniature Weaving Frames

Background: Several materials have been used for tissue engineering purposes, since the ideal matrix depends on the desired tissue. Silk biomaterials have come to focus due to their great mechanical properties. As untreated silkworm silk has been found to be quite immunogenic, an alternative could be spider silk. Not only does it own unique mechanical properties, its biocompatibility has been shown already in vivo. In our study, we used native spider dragline silk which is known as the strongest fibre in nature. Methodology/Principal Findings: Steel frames were originally designed and manufactured and woven with spider silk, harvesting dragline silk directly out of the animal. After sterilization, scaffolds were seeded with fibroblasts to analyse cell proliferation and adhesion. Analysis of cell morphology and actin filament alignment clearly revealed adherence. Proliferation was measured by cell count as well as determination of relative fluorescence each after 1, 2, 3, and 5 days. Cell counts for native spider silk were also compared with those for trypsin-digested spider silk. Spider silk specimens displayed less proliferation than collagen-and fibronectin-coated cover slips, enzymatic treatment reduced adhesion and proliferation rates tendentially though not significantly. Nevertheless, proliferation could be proven with high significance (p<0.01). Conclusion/Significance: Native spider silk does not require any modification to its application as a biomaterial that can rival any artificial material in terms of cell growth promoting properties. We could show adhesion mechanics on intracellular level. Additionally, proliferation kinetics were higher than in enzymatically digested controls, indicating that spider silk does not require modification. Recent findings concerning reduction of cell proliferation after exposure could not be met. As biotechnological production of the hierarchical composition of native spider silk fibres is still a challenge, our study has a pioneer role in researching cellular mechanics on native spider silk fibres.

Caracterização elementar de ligas metálicas em implantes dentários

An ideal biomaterial for dental implants must have very high biocompatibility, which means that such materials should not provoke any serious adverse tissue response. Also, used metal alloys must have high fatigue resistance due the masticatory force and good corrosion resistance. These properties are rendered by using alpha and beta stabilizers, such as Al, V, Ni, Fe, Cr, Cu, Zn. Commercially pure titanium (TiCP) is used often for dental and orthopedic implants manufacturing. However, sometimes other alloys are employed and consequently it is essential to research the chemical elements present in those alloys that could bring prejudice for the health. Present work investigated TiCP metal alloys used for dental implant manufacturing and evaluated the presence of stabilizing elements within existing limits and standards for such materials. For alloy characterization and identification of stabilizing elements it was used EDXRF technique. This method allows to perform qualitative and quantitative analysis of the materials using the spectra of the characteristic X-rays emitted by the elements present in the metal samples. The experimental setup was based on two X- rays tubes (AMPTEK Mini X model with Ag and Au targets), a X-123SDD detector (AMPTEK) and a 0.5mm Cu collimator, developed due to the sample characteristics. The other experimental setup used as a complementary technique is composed of an X-ray tube with a Mo target, collimator 0.65mm and XFlash (SDD) detector - ARTAX 200 (BRUKER). Other method for elemental characterization by energy dispersive spectroscopy (EDS) applied in present work was based on Scanning Electron Microscopy (SEM) EVO® (Zeeis). This method also was used to evaluate the surface microstructure of the sample. The percentual of Ti obtained in the elementary characterization was among 93.35 ± 0.17% and 95.34 ± 0.19 %. These values are considered below the reference limit of 98.635% to 99.5% for TiCP, established by Association of metals centric materials engineers and scientists Society (ASM). The presence of elements Al and V in all samples also contributed to underpin the fact that are not TiCP implants. The values for Al vary between 6.3 ± 1.3% and 3.7 ± 2.0% and for V, between 0.26 ± 0.09% and 0.112 ± 0.048%. According to the American Society for Testing and Materials (ASTM), these elements should not be present in TiCP and in accordance with the National Institute of Standards and Technology (NIST), the presence of Al should be <0.01% and V should be of 0.009 ± 0.001%. Obtained results showed that implant materials are not exactly TiCP but, were manufactured using Ti-Al-V alloy, which contained Fe, Ni, Cu and Zn. The quantitative analysis and elementary characterization of experimental results shows that the best accuracy and precision were reached with X-Ray tube with Au target and collimator of 0.5 mm. Use of technique of EDS confirmed the results of EDXRF for Ti-Al-V alloy. Evaluating the surface microstructure by SEM of the implants, it was possible to infer that ten of the thirteen studied samples are contemporaneous, rough surface and three with machined surface.

Bioremediation of phosphates in seawater: approach for recirculating marine aquaculture effluents

Marine Recirculating Aquaculture Systems (RAS) produce great volume of wastewater, which may be reutilized/recirculated or reutilized after undergoing different treatment/remediation methods, or partly discharged into neighbour water-bodies (DWW). Phosphates, in particular, are usually accumulated at high concentrations in DWW, both because its monitoring is not compulsory for fish production since it is not a limiting parameter, and also because there is no specific treatment so far developed to remove them, especially in what concerns saltwater effluents. As such, this work addresses two main scientific questions. One of them regards the understanding of the actual (bio)remediation methods applied to effluents produced in marine RAS, by identifying their advantages, drawbacks and gaps concerning their exploitation in saltwater effluents. The second one is the development of a new, innovative and efficient method for the treatment of saltwater effluents that potentially fulfil the gaps identified in the conventional treatments. Thereby, the aims of this thesis are: (i) to revise the conventional treatments targeting major contaminants in marine RAS effluents, with a particular focus on the bioremediation approaches already conducted for phosphates; (ii) to characterize and evaluate the potential of oyster-shell waste collected in Ria de Aveiro as a bioremediation agent of phosphates spiked into artificial saltwater, over different influencing factors (e.g., oyster-shell pre-treatment through calcination, particle size, adsorbent concentration). Despite the use of oyster-shells for phosphorous (P) removal has already been applied in freshwater, its biosorptive potential for P in saltwater was never evaluated, as far as I am aware. The results herein generated showed that NOS is mainly composed by carbonates, which are almost completely converted into lime (CaO) after calcination (COS). Such pre-treatment allowed obtaining a more reactive material for P removal, since higher removal percentages and adsorption capacity was observed for COS. Smaller particle size fractions for both NOS and COS samples also increased P removal. Kinetic models showed that NOS adsorption followed, simultaneously, Elovich and Intraparticle Difusion kinetic models, suggesting that P removal is both a diffusional and chemically rate-controlled process. The percentage of P removal by COS was not controlled by Intraparticle Diffusion and the Elovich model was the kinetic model that best fitted phosphate removal. This work demonstrated that waste oyster-shells, either NOS or COS, could be used as an effective biosorbent for P removal from seawater. Thereby, this biomaterial can sustain a cost-effective and eco-friendly bioremediation strategy with potential application in marine RAS.

Avaliação do estresse oxidativo induzido por superfícies de titânio

Commercially pure Titanium (cp Ti) is a material largely used in orthopedic and dental implants due to its biocompatibility properties. Changes in the surface of cp Ti can determine the functional response of the cells such as facilitating implant fixation and stabilization, and increased roughness of the surface has been shown to improve adhesion and cellular proliferation. Various surface modification methods have been developed to increase roughness, such as mechanical, chemical, electrochemical and plasma treatment. An argon plasma treatment generates a surface that has good mechanical proprieties without chemical composition modification. Besides the topography, biological responses to the implant contribute significantly to its success. Oxidative stress induced by the biomaterials is considered one of the major causes of implant failure. For this reason the oxidative potential of titanium surfaces subjected to plasma treatment was evaluated on this work. CHO-k1 cells were cultivated on smooth or roughed Ti disks, and after three days, the redox balance was investigated measuring reactive oxygen species (ROS) generation, total antioxidant capacity and biomarkers of ROS attack. The results showed cells grown on titanium surfaces are subjected to intracellular oxidative stress due to hydrogen peroxide generation. Titanium discs subjected to the plasma treatment induced less oxidative stress than the untreated ones, which resulted in improved cellular ability. Our data suggest that plasma treated titanium may be a more biocompatible biomaterial.

Preparación y caracterización de biomateriales híbridos de hidroxiapatito con fosfonato (2-Hidroxi fosfonoacetato)

El hidroxiapatito es el biomineral de los tejidos duros de los mamíferos y por ello ha sido ampliamente estudiado como biomaterial en cementos óseos, recubrimientos de metales implantables y scaffold en ingeniería de tejidos. En este trabajo, se estudia un proceso síntesis y caracterización de un derivado de este material, donde el ion fosfonato: 2- hidroxifosfonoacetato sustituye parcialmente al ion fosfato [1-10%]. El proceso de síntesis de hidroxiapatito consiste en dos etapas: (1) una reacción a 100ºC entre el ácido fosfórico (añadido lentamente) y una mezcla de hidróxido de calcio + 2-hidroxifosfonoacetato de calcio (Relación Ca/P=1.67). (2) un tratamiento térmico de los sólidos obtenidos en (1) a 150ºC. Los productos finales se han caracterizado mediante análisis químico, análisis termogravimétrico, difracción de rayos-X con análisis de Rietveld, microscopía SEM y determinación de la superficie específica y porosidad. En las fases cristalinas, el grado de pureza de los hidroxiapatitos oscila entre 91-100%. Todos presentan estructura monoclínica, en contraste con la estructura hexagonal que habitualmente se obtiene aplicando métodos de síntesis similares. Esta variación se atribuye a la presencia de fosfonato. El contenido de éste también influye en la morfología y en la porosidad de los materiales, siendo las muestras con más fosfonato las más porosas. Los materiales, al menos aquellos con una cantidad menor o igual 5% de fosfonato, muestran una biocompatibilidad similar a un material de hidroxiapatito de referencia.

Análise da estabilidade genética de células-tronco mesenquimais humanas

Human multipotent mesenchymal stromal cells (MSCs), also known as mesenchymal stem cells, have become an important and attractive therapeutic tool since they are easily isolated and cultured, have in vitro expansion potential, substantial plasticity and secrete bioactive molecules that exert trophic effects. The human umbilical cord as a cell source for cell therapy will help to avoid several ethical, political, religious and technical issues. One of the main issues with SC lines from different sources, mainly those of embryonic origin, is the possibility of chromosomal alterations and genomic instability during in vitro expansion. Cells isolated from one umbilical cord exhibited a rare balanced paracentric inversion, likely a cytogenetic constitutional alteration, karyotype: 46,XY,inv(3)(p13p25~26). Important genes related to cancer predisposition and others involved in DNA repair are located in 3p25~26. Titanium is an excellent biomaterial for bone-implant integration; however, the use can result in the generation of particulate debris that can accumulate in the tissues adjacent to the prosthesis, in the local bone marrow, in the lymph nodes, liver and spleen. Subsequently may elicit important biological responses that aren´t well studied. In this work, we have studied the genetic stability of MSC isolated from the umbilical cord vein during in vitro expansion, after the cryopreservation, and under different concentrations and time of exposition to titanium microparticles. Cells were isolated, in vitro expanded, demonstrated capacity for osteogenic, adipogenic and chondrogenic differentiation and were evaluated using flow cytometry, so they met the minimum requirements for characterization as MSCs. The cells were expanded under different concentrations and time of exposition to titanium microparticles. The genetic stability of MSCs was assessed by cytogenetic analysis, fluorescence in situ hybridization (FISH) and analysis of micronucleus and other nuclear alterations (CBMN). The cells were able to internalize the titanium microparticles, but MSCs preserve their morphology, differentiation capacity and surface marker expression profiles. Furthermore, there was an increase in the genomic instability after long time of in vitro expansion, and this instability was greater when cells were exposed to high doses of titanium microparticles that induced oxidative stress. It is necessary always assess the risks/ benefits of using titanium in tissue therapy involving MSCs, considering the biosafety of the use of bone regeneration using titanium and MSCs. Even without using titanium, it is important that the therapeutic use of such cells is based on analyzes that ensure quality, security and cellular stability, with the standardization of quality control programs appropriate. In conclusion, it is suggested that cytogenetic analysis, FISH analysis and the micronucleus and other nuclear alterations are carried out in CTMH before implanting in a patient